Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DTaP-IPV (DD-687) vs DTaP + OPV in Japanese infants
jRCT2080221313Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Nov 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of diphtheria + tetanus + acellular pertussis + inactivated poliovirus vaccine (adsorbed) in diphtheria, Tetanus, pertussis and 1 more (2 arms), sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
diphtheria + tetanus + acellular pertussis + inactivated poliovirus vaccine (adsorbed)
03
Conditions
diphtheriaTetanuspertussispoliomyelitis
Beyond the preview
Go deeper on jRCT2080221313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221313.